Robert Uhl | Westwicke Partners |
Richard Fair | President, CEO & Director |
Wangzhi Li | Ladenburg Thalmann & Co. |
Greetings, and welcome to the Bellicum Pharmaceuticals Fourth Quarter 2020 Financial Results and Corporate Update Conference Call. [Operator Instructions]. I will now turn the conference over to our host, Robert Uhl of Westwicke ICR. Thank you.
You may begin.